TimesNews

Sports

Ascletis Reports Preclinical Data For Oral Obesity Candidate ASC36o

Times News world desk (2026-10-20): (RTTNews) - Ascletis Pharma Inc. (1672.HK, ASCLF.PK), a biotechnology company, reported preclinical data for ASC36o, a once-weekly oral amylin receptor… Primary source: original at Nasdaq Market Structure (nasdaq.com).

· Nasdaq Market Structure

Ascletis Reports Preclinical Data For Oral Obesity Candidate ASC36o

(RTTNews) - Ascletis Pharma Inc. (1672.HK, ASCLF.PK), a biotechnology company, reported preclinical data for ASC36o, a once-weekly oral amylin receptor peptide agonist being developed for obesity and metabolic diseases.

Read at source